ECMO in Cardiac arrest has increased exponentially in the past 10 years, on the back of, up until very recently, non-randomised, predominantly retrospective studies.
What is the efficacy?
Appropriate patient selection?
Cost effectiveness and model of delivery of ECPR?
Finally is ECMO really the intervention or just optimising the chain of survival?
Podden och tillhörande omslagsbild på den här sidan tillhör Coda Change. Innehållet i podden är skapat av Coda Change och inte av, eller tillsammans med, Poddtoppen.
